For the first time in Egypt and Africa, Hospital 57357 acquires Cyberknife technology: Extremely accurate high dose radiation targeting, decreased treatment duration, better chances for cure

At Hospital 57357, management and staff are rejoicing over the recent signing of the purchasing contract of the cyberknife treatment technology system. CyberKnife treatment is a non-surgical treatment for cancerous or non-cancerous tumors, by using image guidance software to track and continually adjust to locate the tumor, delivering high doses of radiation precisely to the target area of treatment. This precision protects  normal, healthy tissue, while the higher dosage offers improved chances for cure from cancer. The CyberKnife can treat inoperable and hard to reach cancerous tumors. CyberKnife treatment can be used anywhere in the body such as the brain, lung, prostate, pancreas, liver, and spine

For children with brain tumors cancer, Cyberknife is particularly effective.  Treatment with CyberKnife results in potentially fewer complications than invasive surgery and often allows patients to have a better quality of life during and after treatment.

The difference of CyberKnife treatment and radiation therapy, is that CyberKnife treatment does not require surgery, whereas radiation therapy is often performed in conjunction with surgery. “CyberKnife is normally carried out over several days, usually in 1 to 5 sessions, making the time scale a lot quicker and more efficient than with radiation therapy,” explains Dr. Mohamed Saad Zaghloul, head of Radiotherapy department.

Also, the CyberKnife System uses image guidance software to track and continually adjust treatment for any patient or tumor movement. Unlike in any other similar treatments, where sometimes extreme procedures can be used to keep patients in place, it allows patients to breathe normally and relax comfortably during treatment.

Eng. Reda Atta, Head of 57357’s Bio-medical Engeneering Department who represented the Hospital for the contract signing shares that we would need up to 6 to 7 months to make ready the special set-up that will accommodate the new technology which is acquired from AB Care Medical, the agent  of the oversees manufacturing company Accuray in Egypt.